PMID- 37475577 OWN - NLM STAT- MEDLINE DCOM- 20240311 LR - 20240311 IS - 1939-0041 (Electronic) IS - 1939-0041 (Linking) VI - 16 IP - 1 DP - 2024 Jan-Feb TI - Ultrasound-mediated nano-sized drug delivery systems for cancer treatment: Multi-scale and multi-physics computational modeling. PG - e1913 LID - 10.1002/wnan.1913 [doi] AB - Computational modeling enables researchers to study and understand various complex biological phenomena in anticancer drug delivery systems (DDSs), especially nano-sized DDSs (NSDDSs). The combination of NSDDSs and therapeutic ultrasound (TUS), that is, focused ultrasound and low-intensity pulsed ultrasound, has made significant progress in recent years, opening many opportunities for cancer treatment. Multiple parameters require tuning and optimization to develop effective DDSs, such as NSDDSs, in which mathematical modeling can prove advantageous. In silico computational modeling of ultrasound-responsive DDS typically involves a complex framework of acoustic interactions, heat transfer, drug release from nanoparticles, fluid flow, mass transport, and pharmacodynamic governing equations. Owing to the rapid development of computational tools, modeling the different phenomena in multi-scale complex problems involved in drug delivery to tumors has become possible. In the present study, we present an in-depth review of recent advances in the mathematical modeling of TUS-mediated DDSs for cancer treatment. A detailed discussion is also provided on applying these computational models to improve the clinical translation for applications in cancer treatment. This article is categorized under: Nanotechnology Approaches to Biology > Nanoscale Systems in Biology Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease. CI - (c) 2023 The Authors. WIREs Nanomedicine and Nanobiotechnology published by Wiley Periodicals LLC. FAU - Moradi Kashkooli, Farshad AU - Moradi Kashkooli F AUID- ORCID: 0000-0003-4338-8538 AD - Department of Physics, Toronto Metropolitan University, Toronto, Ontario, Canada. FAU - Hornsby, Tyler K AU - Hornsby TK AUID- ORCID: 0000-0001-5702-0596 AD - Department of Physics, Toronto Metropolitan University, Toronto, Ontario, Canada. FAU - Kolios, Michael C AU - Kolios MC AUID- ORCID: 0000-0002-9994-8293 AD - Department of Physics, Toronto Metropolitan University, Toronto, Ontario, Canada. AD - Institute for Biomedical Engineering, Science and Technology (iBEST), Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, Ontario, Canada. FAU - Tavakkoli, Jahangir Jahan AU - Tavakkoli JJ AUID- ORCID: 0000-0003-1947-4479 AD - Department of Physics, Toronto Metropolitan University, Toronto, Ontario, Canada. AD - Institute for Biomedical Engineering, Science and Technology (iBEST), Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, Ontario, Canada. LA - eng GR - ALLRP 556270-20/Natural Sciences and Engineering Research Council of Canada (NSERC) Alliance grants/ GR - RGPIN-2022-03799/Natural Sciences and Engineering Research Council of Canada (NSERC) Alliance grants/ GR - RGPIN-2022-04143/Natural Sciences and Engineering Research Council of Canada (NSERC) Alliance grants/ GR - Ontario Research Fund-Research Excellence (ORF-RE #RE02-032)/ GR - NSERC Banting Postdoctoral Fellowship/ GR - Toronto Poly Clinic Inc/ PT - Journal Article PT - Review DEP - 20230720 PL - United States TA - Wiley Interdiscip Rev Nanomed Nanobiotechnol JT - Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology JID - 101508311 RN - 0 (Nanoparticle Drug Delivery System) SB - IM MH - Humans MH - Nanoparticle Drug Delivery System MH - Drug Delivery Systems MH - *Neoplasms/diagnostic imaging/drug therapy MH - Computer Simulation MH - *Nanoparticles MH - Physics OTO - NOTNLM OT - mathematical model of drug release kinetics from nanoparticles OT - multi-physics and multi-scale computational modeling OT - nano-sized drug delivery systems OT - solid tumor OT - therapeutic ultrasound OT - ultrasound-mediated drug delivery EDAT- 2023/07/21 06:43 MHDA- 2024/03/11 06:43 CRDT- 2023/07/21 02:53 PHST- 2023/05/18 00:00 [revised] PHST- 2022/12/12 00:00 [received] PHST- 2023/05/30 00:00 [accepted] PHST- 2024/03/11 06:43 [medline] PHST- 2023/07/21 06:43 [pubmed] PHST- 2023/07/21 02:53 [entrez] AID - 10.1002/wnan.1913 [doi] PST - ppublish SO - Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Jan-Feb;16(1):e1913. doi: 10.1002/wnan.1913. Epub 2023 Jul 20.